Stefan Gruenwald

Diagnomics, Inc. engages in the research and development of personalized advanced healthcare services. It offers consumer genomics solutions, analysis platform, clinical and translational research, assay development support, and bioinformatics services. The company was founded by Min Seob Lee, Stefan Gruenwald, and Dan Scholefield in 2011 and is headquartered in San Diego, CA.

Quadraspec, Inc. is a diagnostic company engaged in the development of in-vitro diagnostic products for the laboratory, clinical, research and life sciences markets. Their products are used in veterinary for canine heartworm, by biotechnology companies for assay development, biomarker identification, and patient screening during pre-clinical and clinical development and in clinical diagnostics. It developed a direct detection technology which eliminates the usage of secondary and labeled reagents. The company’s proprietary Spinning Disc Interferometry (SDI) Detection technology platform detects and quantifies more than 1,000 unique antigens, biomarkers, or other molecular species on a single array providing a reagent-free detection technology. Its dual channel detector, Inspira Reader features reagent-free detection and orthogonal detection method for quantification of molecular assays. The company was founded in 2004 and is headquartered in West Lafayette, Indiana.

Part of Becton, Dickinson & Co., PharMingen is a company that manufactures antibodies and reagents for biological research. The company is based in San Diego, CA. PharMingen was acquired by Becton, Dickinson & Co. on May 19, 1997.